Ground-Breaking Data from the Phase III ADAURA Trial
EP. 1: Adjuvant Treatment of EGFR+ NSCLC: Standard of Care
By
Targeted Oncology
July 9th 2020
EP. 2: Ground-Breaking Data: Phase 3 ADAURA Trial
By
Targeted Oncology
July 9th 2020
EP. 3: Third-Generation Versus Earlier-Generation Agents
By
Targeted Oncology
July 9th 2020
EP. 4: ADAURA Phase III Trial Data: Practice Changing?
By
Targeted Oncology
July 9th 2020
